Rural Community Hospital Demonstration Program Reauthorization
HB8967, titled the Rural Community Hospital Demonstration Program Reauthorization, would extend the federal rural community hospital demonstration program from a 15-year extension period to a 20-year extension period. The bill amends section 410A of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 to replace references to the 15-year extension with 20-year language throughout the statute and related conforming provisions.
The measure also adds a new rule for certain hospitals that were not original participants in the demonstration. Under the bill, during the fourth five years of the new 20-year extension period, the Secretary of Health and Human Services would apply the same provisions to qualifying rural community hospitals that participated in the program at any time between December 30, 2024, and January 1, 2027, in a manner similar to original participant hospitals. In practical terms, the bill keeps the demonstration program operating longer and broadens the timing window for some non-original participants to receive comparable treatment.
The bill would amend federal Medicare law, specifically section 410A of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, by extending the rural community hospital demonstration program and updating all related statutory references from a 15-year to a 20-year extension period. It would affect the administration of Medicare payment and demonstration rules for rural community hospitals, and could expand access to the program for certain hospitals that participated during the specified 2024-2027 period.
The available context suggests generally favorable sentiment toward the bill. The measure was introduced with bipartisan and cross-state support from a large group of House members, including members from both parties and multiple regions, which indicates broad interest in continuing the rural hospital demonstration. No committee transcript or recorded vote is provided, so there is no evidence in the supplied materials of organized opposition or a contentious markup.
The main policy issue appears to be the scope and duration of the extension rather than the existence of the program itself. The bill’s added provision for hospitals that were not original participants may be the most notable point of potential debate, because it expands eligibility treatment to a broader set of rural hospitals that participated during a later window. Any contention would likely center on whether extending the program for five additional years and applying comparable rules to more hospitals is the best use of Medicare policy and federal resources, but no explicit objections are included in the record provided.